All News

The 4-drug combination tablet (Symtuza) was approved by the FDA in July 2018 for infection of HIV type 1 (HIV-1) in treatment-naïve and certain virologically suppressed adults.

The digital solution is designed to help build foundational knowledge and skills, while assessing users' areas of strength and areas of needed focus.

The APPA industry awards each year recognize outstanding performances in the pharmactical industry, lauding both companies and individuals for their innovation, dedication and best-in-class service.

The AMCP Managed Care & Specialty Pharmacy Annual Meeting featured various discussions on strategies to manage complex patients and achieve optimal outcomes, highlighted by an exciting string of innovations and policy shifts.

Top news of the day from across the health care landscape.

What is an antioxidant, and how do they affect our health?

As specialty pharmacies continue to grow, health systems will need to evaluate whether an integrated specialty pharmacy is right for them.

Romosozumab-aqqg (Evenity, Amgen) works to decrease the risk of fracture by increasing new bone formation in women with postmenopausal osteoporosis.

Romosozumab-aqqg (Evenity, Amgen) works to decrease the risk of fracture by increasing new bone formation in women with postmenopausal osteoporosis.

On Tuesday, a US Senate Finance Committee hearing on drug pricing focused on addressing the role of pharmacy benefit managers (PBMs) in determining cost to patients.

The hearing, “Drug Pricing in America: A Prescription for Change, Part III,” gave PBMs a chance to testify about the issue and provide insight into what the role entails.

Plague is a serious medical condition recognized by public health authorities globally as a potential agent of bioterrorism.

A shortage of pharmacy technicians affects both hospitals and retail pharmacies and requires employers to focus on building a pipeline of job candidates who possess the skills they need.

Approximately 1 in 5 patients in a study were misdiagnosed with multiple sclerosis before being referred to treatment centers.

Top news of the day from across the health care landscape.

Drug-drug interactions are considered on a daily basis, but it may also be important to consider food-drug interactions as this may also impact overall efficacy and safety of certain medications.

Amgen’s ABP 501 (Amjevita) shows similar efficacy to the reference adalimumab (Humira) in treating rheumatoid arthritis and supported approval of the biosimilar by the FDA.

The Next-Generation Pharmacist® Awards program recognizes pioneers, innovators and future leaders in the pharmacy industry. Pharmacist nominations represent chain, independent and specialty pharmacies; government and academic institutions; long-term care facilities; and health-system pharmacists.

With this approval, patients who have never been treated have the option of a 2-drug regimen in a single tablet, as opposed to the standard-of-care 3-drug regimen for HIV.

With this approval, patients with HIV who have never been treated have the option of a 2-drug regimen in a single tablet.

Efficiency means doing things right, while effectiveness means doing the right things.

Adenosine deaminase is an ultra-rare and inherited disorder that is detrimental to the immune system and causes severe combined immune deficiency.

Brain stem cells of patients with primary progressive multiple sclerosis appear to age faster.

Top news of the day from across the health care landscape.

Sun Pharma's gemcitabine in sodium chloride injection is the first and only chemotherapy product in a premixed, ready-to-infuse formulation, which eliminates steps in the complex chemotherapy preparation process.

Why is this woman taking a drug used to treat prostate problems?

Physicians who used an electronic health record system found to have a better cognitive workload and performance.

If these products were confused, it coul result in someone ingesting "could result in ingesting toxic amounts of liquid nicotine. Likewise, nicotine exposures of these sorts are extremely problematic and could be fatal for children."

Enfortumab vedotin is being investigated for the treatment of locally advanced or metastatic urothelial cancer following both platinum-containing chemotherapy and a PD-1 or PD-L1 inhibitor.

Top news of the day from across the health care landscape.